We studied the role of microsomal triglyceride transfer protein (MTP) in the synthesis, secretion, and cotranslational degradation of apolipoprotein (apo) B using nonhepatic COS-7 cells that expressed C-terminally truncated forms of apoB (from apoB15 to apoB94) with or without the large subunit of human MTP. With the exception of apoB15 and apoB18, secretion of all of the apoB forms was stimulated by expression of MTP, even though a small amount of short apoB forms ( apoB48) could be secreted by cells transfected with apoB alone. The majority of the apoB protein, including apoB72 and apoB94, was secreted as high density lipoprotein (1.08 -1.17 g/ml). Pulse-chase experiments revealed that the secretion efficiency of apoB94 and apoB72 was low (ranging from 2 to 12%). The failure to secrete buoyant lipoproteins and the low secretion efficiency were associated with insufficient lipid synthesis by the cells. The incorporation of [ 3 H]oleate into cellular triglyceride and phosphatidylcholine by COS cells over a 2-h period was 28 and 38%, respectively, of that by rat hepatoma (McA-RH7777) cells. In addition to the desired fulllength apoB, cells transfected with large constructs ( apoB60) also produced smaller species with a size of ϳ220 kDa (designated B48-like protein). Coexpression with MTP decreased formation of the B48-like proteins by 40 -60%. The reduction in B48-like protein formation was specific to MTP expression; coexpression with other proteins (e.g. apoA-I or apoB15) did not alter B48-like protein production. Kinetic analysis suggested that B48-like proteins were produced concurrently (cotranslational) with the full-length apoB94 and apoB72 and were not products of post-translational degradation. Although some of the B48-like proteins might be derived from truncated species (ϳ7 kb in size) of apoB mRNA that were found in cells transfected with large apoB constructs, MTP coexpression did not affect the relative levels of the aberrant 7-kb RNA with respect to the fulllength mRNA. However, coexpression of MTP decreased the accessibility of apoB to exogenous trypsin by 2-fold for apoB72 and by 10-fold for apoB94 in isolated microsomes. Thus, the reduced B48-like protein formation by MTP may be a consequence of attenuated cotranslational degradation during apoB translocation across the ER membrane. Formation of B48-like proteins was insensitive to N-acetyl-leucyl-leucyl-norleucinal, a cysteine protease inhibitor known to block post-translational degradation of apoB. These results indicate that MTP facilitates the assembly and secretion of lipoproteins containing apoB and also attenuates the formation of B48-like proteins, probably by assisting apoB translocation across the ER membrane.
The large subunit of the microsomal triglyceride transfer protein (MTP) 1 is a 97-kDa protein expressed exclusively in the liver and intestine, which plays an obligatory role in the production of apolipoprotein (apo) B-containing lipoproteins (LpB) (1) . Deficiency of MTP activity, resulting from mutations in the MTP gene, is the proximal cause of human familial abetalipoproteinemia (2, 3) . Recent evidence, obtained in heterologous cell systems where recombinant human apoB was coordinately expressed with human MTP (4, 5) , has suggested that MTP and apoB together are sufficient for the assembly and secretion of LpB. However, the mechanisms by which MTP facilitates the assembly process have not been fully elucidated. Studies with cultured hepatic cells have shown that lipid recruitment occurs cotranslationally during apoB translocation across the endoplasmic reticulum (ER) membrane (6) and that the size of the initially resulting lipoprotein particle is governed by the length of apoB polypeptide chain (7, 8) . Thus, MTP may facilitate lipoprotein assembly by assisting in the recruitment of lipids by apoB, by accelerating apoB translocation across the ER membrane, or both.
A rate-limiting step in LpB formation is perhaps the translocation of apoB across the ER membrane. Using the N-terminal 15% of apoB (apoB15) as a model, Chuck and co-workers (9 -11) have observed that translocation of apoB proceeds posttranslationally through discrete stop-and-restart stages mediated by "pause transfer" sequences. Recently, evidence obtained from studies with Chinese hamster ovary and HepG2 cells (12, 13) has suggested that arrested ER translocation of apoB could result in the production of discrete truncated forms (ϳ70 -85 kDa) derived from the N-terminal portion of apoB. The mechanisms responsible for the arrest of apoB translocation across the ER membrane are unclear, because long continuous stretches of hydrophobic residues typically found in membrane spanning peptides do not exist in apoB (14) . It is conceivable that some of the pause transfer sequence motifs that exist throughout the apoB100 molecule (10) may be involved in the prolonged translocation arrest. The nascent apoB, which is trapped in such a transmembrane configuration, could become susceptible to degradation, even before the translation of the full-length apoB has been completed. This cotranslational degradation of apoB during polypeptide chain elongation may represent an additional regulatory step controlling hepatic apoB synthesis, which is kinetically and biochemically distinct from the post-translational degradation of newly synthesized apoB described previously (15, 16) . Furthermore, unlike posttranslational degradation of apoB where the entire apoB polypeptide disappears, the cotranslational cleavage yields discrete products that can still be secreted (12) .
In a similar fashion, we have previously observed truncated species of apoB (ϳ220 kDa in size, designated B48-like protein) in rat hepatoma McA-RH7777 cells transfected with cDNAs encoding human apoB species longer than apoB48 (7, 8, 18) . These proteins were secreted as high density lipoproteins (HDL). Attempts to eliminate B48-like protein formation by site-specific mutagenesis at or near the apoB mRNA editing site were successful only with a cDNA construct encoding apoB53 (8, 19) . Epitope mapping experiments and pulse-chase analysis have indicated that the 220-kDa protein is derived from the N-terminal portion of human apoB100, and its formation is not caused by post-translational degradation of a precursor protein (19) . One mechanism responsible for the formation of B48-like protein in transfected McA-RH7777 cells is alternative polyadenylation of the human apoB mRNA (20, 21) . Utilization of cryptic polyadenylation signals in the middle of the human apoB message could result in premature termination of apoB translation. It has been suggested that alternative polyadenylation of the human apoB mRNA occurs only in cells that contain the apoB mRNA editing activity (21) . However, we have observed the formation of B48-like protein in human apoB-transfected COS-7 cells (18) , a cell line that does not contain the apoB mRNA editing activity (22) . Thus, formation of B48-like protein could be mediated by mechanisms independent of apoB mRNA editing or alternative polyadenylation. We hypothesize that production of the B48-like protein is mediated by degradation of a translocation arrested intermediate during or immediately after apoB translation.
In the present study, we have examined the role of MTP in the synthesis, secretion, and cotranslational degradation of apoB using COS-7 cells transfected with C-terminally truncated human apoB forms (ranging from apoB15 to apoB94) with or without cotransfection of the MTP large subunit. We find that coexpression of MTP enhances secretion of apoB forms that have the ability to assemble a neutral lipid core and reduces proteolytic truncation of apoB forms larger than apoB53. These results support the hypothesis that MTP facilitates LpB assembly and secretion and attenuates cotranslational degradation of apoB, probably by assisting apoB translocation across the ER membrane. H]Glycerol (9.6 Ci/mmol) and [9, H]oleic acid (9.2 Ci/mmol) were obtained from ICN Pharmaceuticals Canada Ltd., and DuPont NEN, respectively. Monoclonal antibodies specific for human apoB (1D1, 4G3, and 3F5) and for human apoA-I (5F6) were gifts from R. W. Milne and Y. L. Marcel (University of Ottawa Heart Institute, Ottawa). Rabbit antibody to bovine protein disulfide isomerase was a gift from M. Michalak (University of Alberta). Goat antihuman MTP large subunit antiserum was prepared as described previously (4). Brefeldin A, oleic acid, cholesterol, and peroxidaseconjugated rabbit anti-goat immunoglobulin G antibody were purchased from Sigma.
EXPERIMENTAL PROCEDURES

Materials
Expression Plasmids-The expression plasmid for human MTP large subunit was prepared as described previously (4) . The expression plasmids for human apoA-I (23), apoB15 (24) , apoB18 and apoB23 (18) , apoB29 (25) , apoB42 (26) , apoB48 (27) , apoB53 (19) , apoB60, apoB72 and apoB94 (8) , and apoB75 2 were prepared as described previously. The plasmids encoding human apoB proteins longer than apoB48 all contained the Leu-Leu mutation (19) within the apoB cDNA in order to prevent apoB48 formation by apoB mRNA editing.
Cell Culture and Transfection-McA-RH7777 and COS-7 cells were obtained from the American Type Culture Collection and were cultured under conditions as described previously (18) . The cells were passed every two and half days at a ratio of 1:5 when the cells were 50 -60% confluent. For transfection experiments, COS cells (100 mm, 15 ml of COS medium) were transfected with expression plasmids encoding human MTP (15 g of DNA) and/or human apoB (30 g of DNA) using the calcium phosphate precipitation technique essentially as described (17) , except that the concentration of calcium chloride used was 4.5-fold higher than previously reported. 4 -5 h after transfection, the cells were subjected to glycerol shock and incubated for 24 h with Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (COS medium). In some experiments, transfection of COS cells was conducted using cells that were plated on 60-mm (5 ml of medium) dishes. The DNAs used for transfection were 5 g for the human MTP and 10 g for apoB, and calcium chloride concentration was 1.5-fold higher than previously reported (17) . In control cotransfection experiments, COS cells (60-mm dishes) were either transfected with 10 g of apoB cDNA alone or cotransfected with apoB (apoB94 or apoB72) plus 5 g of MTP cDNA, 3 g of apoA-I cDNA, or 4 g of apoB15 cDNA. The molar ratio of apoB (apoB94 or apoB72) versus apoB15 or apoA-I cDNA was the same as that for apoB and MTP.
Preparation of RNA and Northern Blot Analysis-Total cellular RNA was isolated from transfected cells using Tri Reagent provided by Molecular Research Center, Inc. (Cincinnati, OH) according to the manufacturer's instructions. 20 g of total RNA was resolved on a 1% agarose gel containing 6% formaldehyde. Northern blot analysis was carried out as described previously (27) using a SacI-SacI human apoB fragment (nucleotides 3194 -3835 of the human apoB cDNA) as a probe.
Determination of ApoB Synthesis-Synthesis of apoB was determined by either continuous labeling or by pulse-chase analysis. In continuous labeling experiments, 24 h after transfection the cells (100 mm) were trypsinized and plated onto four 60-mm Primaria dishes. The cells were then incubated with lipid feeding medium (DMEM supplemented with 20% fetal bovine serum and 0.8 mM oleate/0.8% bovine serum albumin) for 12-14 h. After this incubation, the cells (ϳ60% confluent) were washed with methionine-and cysteine-free DMEM and incubated with 1.5 ml of labeling medium (methionine-and cysteinefree DMEM containing 20% fetal bovine serum, 0.8 mM oleate, and 200 Ci/ml [ 35 S]methionine/cysteine) for up to 4 h. In pulse-chase experiments, the cells were pulse labeled for 5 min with 1.5 ml of labeling medium containing 500 Ci/ml [ 35 S]methionine/cysteine and chased for up to 20 min with chase medium (DMEM containing 20% fetal bovine serum, 0.8 mM oleate, 2 mM methionine, and 0.6 mM cysteine).
Determination of Lipid Synthesis-The metabolic labeling of lipids was performed essentially as described previously (28) . COS and McA-RH7777 cells (30 or 60% confluence in 60-mm dishes) were incubated with the lipid feeding medium for 12-14 h. After the incubation, the cells were washed and incubated with the same medium (2 ml) supplemented with 10 Ci of [2- were identified by comparison with lipid standards; radioactivity associated with the lipids was quantified by scintillation counting. The rate of incorporation of [ ]methionine/cysteine) for 1 h and then chased for up to 2 h in a chase medium. At the indicated time points, media were collected and centrifuged in an Eppendorf microfuge at maximum speed for 2 min to remove cell debris, and apoB proteins were purified by immunoprecipitation using an anti-human apoB antibody as described previously (8) . The cell lysates were also subjected to immunoprecipitation for human apoB (8) or human MTP (29) as described previously.
Density Gradient Ultracentrifugation of Medium Lipoproteins-COS cells transfected with apoB in the presence or the absence of MTP were labeled with [ 35 S]methionine/cysteine (200 Ci/ml) in the labeling medium for 6 h (B94 and B72) or incubated with lipid feeding medium for 20 h (B23, B29, and B42). The conditioned media (6 ml) were supplemented with 0.5 mM EDTA and 0.015% phenylmethylsulfonyl fluoride and subjected to ultracentrifugation in a sucrose density gradient essentially according to the previously described method (30) except that a SW 41-Ti rotor was used. Twelve fractions (1 ml each) were collected from the top of the centrifuge tubes, and apoB was recovered from each fraction by immunoprecipitation as described above. In some experiments, a serum-free labeling medium was used which contained 0.8 mM oleate, 0.05 mg/ml cholesterol, and 1 mM glycerol (4). There was no significant difference in synthesis or secretion of the recombinant apoB between the two labeling conditions, except that incorporation of tracer into apoB was higher using the serum-free labeling medium.
Polyacrylamide Gel Electrophoresis-The apoB, MTP, or apoA-I proteins were resolved by PAGE in the presence of 0.1% SDS (SDS-PAGE) on 5% gels for apoB (except apoB15 and apoB18) and 10% gels for MTP, apoB15, apoB18, and apoA-I. Radioactivity associated with apoB or MTP was quantified by fluorography and liquid scintillation counting as described previously (8) . In some experiments, intensities of the apoB bands on the fluorograms were quantified on a Sharp JX-325 densitometer. Data were processed using ONE-Dscan software (Scanalytics, Billerica, MA) and expressed as integrated absorbance units.
Immunoblot Analysis-Immunoblot analysis of the recombinant human apoB and apoA-I expressed in the cells and secreted into the medium was performed as described previously (18), except that the proteins in the medium were first immunoprecipitated with a polyclonal anti-apoB or anti-apoA-I antiserum prior to SDS-PAGE and immunoblotting.
Microsome Isolation and Digestion with Trypsin-After 12 h of lipid feeding, COS cells (100-mm dish) were collected into 1 ml of microsomal buffer (10 mM Tris-HCl, pH 7.4, 250 mM sucrose) supplemented with protease inhibitors (0.1 mM leupeptin, 0.1 mM phenylmethylsulfonyl fluoride, 100 unit/ml aprotonin, and 40 g/ml ALLN) and homogenized by 20 strokes through a ball-bearing homogenizer (H & Y Enterprise, Redwood City, CA). The microsomes were isolated from the 10,000 ϫ g post-nuclear supernatant by centrifugation for 15 min at 400,000 ϫ g in a Beckman TLA-100.3 rotor, resuspended in 200 l of microsomal buffer without protease inhibitors, and subjected to trypsin digestion as described previously (12) . Brefeldin A and ALLN Treatment-The effect of brefeldin A on apoB secretion was determined by including brefeldin A (final concentration of 1 g/ml) in the lipid feeding medium for 1 h prior to and during 1-h metabolic labeling period. Brefeldin A was added to the media from a stock solution (1 mg/ml in absolute ethanol), and an equivalent amount of ethanol was added to control cells. For ALLN treatment experiments, ALLN (final concentration of 40 g/ml) was added from a stock solution (40 mg/ml in dimethyl sulfoxide) to the culture medium for 2 h prior to and again during 1 h of metabolic labeling.
Other Methods-The MTP activity in transfected COS-7 cells and in mock-transfected HepG2 cells or McA-RH7777 cells was determined as described previously (2) . (4, 5) is a function of apoB length, we systematically examined LpB production using COS cells cotransfected with MTP and truncated forms of apoB, ranging from apoB15 to apoB94. In all the cotransfection experiments, recombinant human MTP (97 kDa) was readily detectable within the cells by immunoblot or immunoprecipitation from radiolabeled cultures but as expected was not present in the medium (data not shown). Under these conditions, the transfected COS cells consistently expressed a measurable level of MTP activity (as determined by transfer of triglyceride), which was approximately 70% of that in mocktransfected HepG2 cells (0.01, 0.24, and 0.34% of triglyceride transfer/h/g of cell protein in mock-transfected COS, MTPtransfected COS, and mock-transfected HepG2 cells, respectively). Fig. 1A shows immunoblots of four small apoB species (i.e. apoB15, apoB18, apoB23, and apoB29) that were expressed and secreted by the cells in the absence or the presence of MTP. The level of secretion of apoB15 and apoB18 was independent of MTP expression, but secretion of apoB23 and apoB29 was FIG. 1. Transient expression of recombinant human apoB15, apoB18, apoB23, and apoB29 in COS-7 cells. A, immunoblots of recombinant apoB15, apoB18, apoB23, and apoB29. COS-7 cells were transfected with the apoB cDNAs alone (ϪMTP) or with both the apoB and MTP cDNAs (ϩMTP) and incubated in COS medium for 36 h. After this incubation, the transfected cells were cultured in serum-free medium (Ϫserum) or medium containing 20% serum and 0.8 mM oleate (ϩserum, ϩoleate) for 20 h, and the conditioned medium was collected. The expressed apoB proteins were recovered from media and cells by immunoprecipitation, resolved by SDS-PAGE, and detected by immunoblotting using monoclonal anti-human apoB antibody 1D1 (32) . B, metabolic labeling studies of apoB29. COS cells (60 mm), transiently transfected with either apoB29 alone (q) or with both apoB29 and MTP (f), were labeled with [ We then examined the effect of MTP expression on the secretion of four larger apoB proteins, namely apoB48, apoB53, apoB72, and apoB94. Again, each of the apoB forms was expressed within the cells (Fig. 2, top) . In cells transfected with apoB cDNAs alone, none of the apoB forms was readily detectable in the medium, even when supplemented with serum and oleate (bottom, lanes marked with ϪMTP). However, the intracellular steady state levels of the apoB proteins were increased by the supplementation (compare ϪMTP lanes, Ϫserum versus ϩserum). Secretion of apoB48 and larger proteins was observed only when cells coexpressed MTP and were stimulated by supplementation of serum and oleate (bottom, lanes marked with ϩMTP). Whereas apoB48, apoB53, and apoB72 were secreted even when the cells were cultured in serum-free medium, apoB94 secretion was entirely dependent upon the presence of serum and oleate, in addition to MTP. These results together suggested that for apoB secretion the requirement for MTP expression and cellular lipogenesis is a function of the apoB length. Notably, despite the presence of the Leu-Leu mutation in the apoB constructs, two proteins of approximately the size of apoB48 were produced by apoB72-and apoB94-transfected cells (B72 and B94, see below). The effect of MTP on apoB secretion was quantified by metabolic labeling experiments using cells transfected with apoB94 alone or with both apoB94 and MTP. Data summarized in Fig. 2B demonstrate that secretion of apoB94 was entirely dependent upon MTP expression. A trace amount of B48-like proteins was detected in the medium of cells transfected with apoB94 alone, and its secretion was stimulated (ϳ3-fold) by MTP expression (Fig. 2B) . To eliminate the possibility that apoB accumulated in the medium as a consequence of cell lysis rather than secretion, we used brefeldin A to disrupt the secretory pathway prior to and during 4 h of metabolic labeling. Fig. 3 demonstrates that although brefeldin A had little effect on the cellular level of 35 S-apoB (top), it completely abolished accumulation of apoB proteins in the medium (bottom). These data indicate that apoB is secreted through a pathway that is sensitive to brefeldin A and that accumulation of apoB in the medium does not result from cell lysis.
RESULTS
Coexpression of MTP Enhances Secretion of ApoB-To determine if MTP-facilitated LpB assembly and secretion
COS-7 Cells Do Not Synthesize Buoyant ApoB-containing Lipoproteins-We used sucrose density gradient ultracentrifugation analysis to examine the extent of lipidation of the apoB proteins secreted from cells transfected with apoB94, apoB72, apoB42, apoB29, or apoB23. Fig. 4A shows the representative sucrose density gradient profiles and Fig. 4B quantification of the apoB proteins in the gradient after centrifugation. In the presence of MTP (B94/ϩMTP), both apoB94 and B48-like proteins were secreted as lipoproteins, majority of apoB94 and all of the B48-like proteins were associated with HDL (d ϭ 1.10 g/ml), and a small amount of apoB94 (Ͻ1% of total secreted) with low density lipoproteins (d ϭ 1.035 g/ml). In apoB72-transfected cells, both apoB72 and B48-like proteins secreted by the cells (B72/ϩMTP) were associated primarily with HDL. FIG. 3 . Effect of brefeldin A on recombinant apoB synthesis and secretion. 1 h prior to and during the labeling period, brefeldin A (1 g/ml) was added to the medium. The 35 S-labeled apoB proteins were immunoprecipitated from cell and medium samples at the end of 4 h of labeling, resolved by SDS-PAGE, and subjected to fluorography. The x-ray film was exposed for 60 h. Repetition of the experiment yielded identical results .   FIG. 2 . Transient expression of recombinant human apoB48, apoB53, apoB72, and apoB94 in COS-7 cells. The experiments were performed essentially as described in Fig. 1 , except using cDNAs for apoB48, apoB53, apoB72, and apoB94. A, immunoblots of recombinant apoB48, apoB53, apoB72, and apoB94. Positions of the truncated apoB variants are shown on the right. B48-like, proteins with the size of apoB48. B, metabolic labeling of recombinant human apoB94 in COS-7 cells transfected with either apoB94 alone (q) or with both apoB94 and MTP (f). Radioactivity associated with medium apoB94 (top) and B48-like protein (bottom) was quantified by scanning densitometry of the fluorograms. The experiments were repeated twice, and essentially identical results were obtained.
These data indicate that the ability of COS cells to secrete large, buoyant lipoprotein particles is limited. The peak density of particles containing apoB29 or apoB23 was at d ϭ 1.17 g/ml (B29/ϩMTP and B23/ϩMTP) and that of apoB42 was d ϭ 1.13 g/ml (B42/ϩMTP). In addition, the same peak density distribution of lipoprotein particles containing apoB23, apoB29, apoB42, and B48-like protein was also observed in the absence of MTP coexpression (data not shown). Together, these data (Fig. 4D ), in agreement with previous observations (8, 18) , demonstrate that the buoyant density of LpB is inversely related to apoB length and suggest that the N-terminal apoB sequences (ՅapoB48) may mediate lipid recruitment autonomously during LpB assembly.
To understand why COS cells were unable to produce large, buoyant lipoproteins, we compared the synthesis rate of lipids (i.e. triglyceride and phosphatidylcholine), apoB, and MTP between COS cells and rat hepatoma McA-RH7777 cells by metabolic labeling. Upon oleate supplementation, lipid droplets were similarly observed microscopically in both COS and McA-RH7777 cells and comparable quantities of intracellular triglyceride were detected by high performance thin-layer chromatography (data not shown). However, during a 2-h labeling period, incorporation of [ 3 H]oleic acid into triglyceride and phosphatidylcholine was 4-and 3-fold, respectively, and lower in COS cells than in McA-RH7777 cells (Table I) . Furthermore, when [ Using apoB94-transfected cells as representative, the synthesis rate of human apoB94 in COS was found to be ϳ13% of that of endogenous rat apoB100 in McA-RH7777 cells (apoB94, ϳ7,500 cpm/h/mg cell protein; rat apoB100, ϳ70,000 cpm/h/mg cell protein). The level of MTP activity in transfected COS cells was comparable (ϳ70%) to that in McA-RH7777 or HepG2 cells (see above). These results suggest that the failure of COS cells to synthesize buoyant lipoproteins may not result from overexpression of recombinant apoB or insufficient expression of MTP. Rather, the inability to assemble and secrete large lipoproteins is probably attributable to insufficient lipid synthesis and impaired utilization of stored lipids by the COS-7 cells.
Coexpression of MTP Reduces ApoB48-like Protein Synthesis-As noted above, the apoB72-or apoB94-transfected cells produced B48-like proteins in addition to the desired fulllength apoBs. Analysis of apoB synthesis by continuous labeling for up to 6 h (data not shown) suggested that apoB94 and B48-like proteins are produced concurrently with no indication of a precursor-product relationship. The inhibitory effect of MTP on B48-like protein formation was also observed in these experiments. At the end of a 6-h labeling period, production of B48-like protein was decreased by 65 and 42%, respectively, by ]methionine/cysteine for 6 h in a serum-free medium supplemented with 0.8 mM oleate, 0.05 mg/ml cholesterol, and 1 mM glycerol (B94/ϩMTP and B72/ϩMTP) or incubated with a medium containing 20% serum and 0.8 mM oleate for 20 h (B23/ϩMTP, B29/ϩMTP, and B42/ϩMTP). The conditioned medium was harvested and subjected to ultracentrifugation in a sucrose density gradient. Twelve fractions were collected from the top of the centrifuge tubes. The apoB proteins in each fraction were recovered by immunoprecipitation, resolved by SDS-PAGE, and subjected to fluorography (B94/ϩMTP and B72/ϩMTP) or immunoblotting using monoclonal antibody 1D1 (B23/ϩMTP, B29/ϩMTP, and B42/ϩMTP). The x-ray film (B94/ϩMTP) was exposed for 17 h for fractions 7-12 and for 4.5 days for fractions 1-6 to visualize the trace amount of apoB94. B, quantification of radioactivity associated with the apoB proteins by liquid scintillation counting (apoB94 and B48-like proteins) or by scanning densitometry (apoB72, apoB42, apoB29, and apoB23). C, density profile of the sucrose gradient after ultracentrifugation. D, relationship between apoB length and the peak density of LpB. f, data from this study; Ç, data from Refs. 8 and 18.
MTP coexpression (in two experiments). To confirm that B48-like proteins are not derived from post-translational degradation of apoB94, we examined protein synthesis by 5-min pulse labeling followed with 20-min chase to minimize the contribution of post-translational degradation. As was the case for continuous labeling, both apoB94 and B48-like proteins were synthesized concurrently, with a higher rate of B48-like protein synthesis than for apoB94 (Fig. 5A) . The ratio of apoB94 to B48-like protein was increased 2-fold; 1.65 Ϯ 0.35 in the presence of MTP versus 0.83 Ϯ 0.20 in the absence of MTP (mean of the four time points, Fig. 5B ). The decreased production of B48-like proteins was specific to MTP expression, because cotransfection with other proteins with a size similar to that of MTP, such as apoB15 or apoA-I, had no effect on the formation of B48-like proteins in apoB94-transfected (Fig. 5C ) or apoB72-transfected (Fig. 5D ) cells. Furthermore, formation of B48-like protein was also observed in cells transfected with apoB60 (see below) or apoB75 (data not shown) but was not observed in apoB53-transfected cells (Fig. 2, B53 ). Immunoblot analysis demonstrated that B48-like proteins were derived from the N-terminal portion of apoB100; they reacted with monoclonal antibody 1D1, which has an epitope at the N terminus of apoB but did not react with antibodies such as 3F5 and 4G3 (data not shown) with epitopes beyond the C terminus of apoB48 (32) .
We also examined whether MTP had an effect on post-translational metabolism of apoB proteins by pulse-labeling for 1 h and chase for up to 2 h (Fig. 6 ). Densitometric scanning of autoradiograms from a representative experiment with apoB94 transfected cells (Fig. 6A ) demonstrated that secretion of apoB94 and B48-like proteins was stimulated by MTP. Quantification of radioactivity associated with medium apoB by scintillation counting revealed that at the end of 2 h chase, 2-3 and 7-8% of the initially labeled apoB94 and B48-like protein, respectively, were secreted into the medium. Expression of MTP had little impact on intracellular retention time of the newly synthesized apoB proteins (Fig. 6A) . Similar results were obtained in parallel studies with apoB72-transfected cells. The secretion efficiency of apoB72 and B48-like protein in apoB72-transfected cells was 12 and 8%, respectively, in the presence of MTP, and the intracellular retention time for both proteins was longer than 2 h (Fig. 6B) . These results further indicate that the reduced B48-like protein level by MTP coexpression is a result of decreased synthesis but not of a posttranslational event. Prematurely polyadenylated products (ϳ7 kb in size) of human apoB message have been observed in some transfected cells (21) . Northern blot analysis of total RNA in apoB94-or apoB72-transfected COS cells also revealed such 7-kb species in addition to the full-length apoB mRNA (Fig.  7A) . Thus, some of the B48-like proteins might be derived from the 7-kb RNA. However, MTP coexpression had little effect on the relative concentrations of the 7-kb species with respect to the full-length apoB mRNAs (Fig. 7B ) in the face of markedly reduced B48-like proteins (Fig. 5, C and D, left panels) . Therefore, it is unlikely that the reduced B48-like protein formation upon MTP coexpression results from altered levels of the aberrant 7-kb species.
Trypsin Digestion of Microsome-associated ApoB-The possibility that the decreased production of B48-like proteins by MTP expression might result from facilitated apoB translocation across the ER membrane was tested by assessing the topology of the full-length apoB associated with the microsomes (Fig. 8) . As was the case in the whole cell lysate (Fig. 5, C and  D) , the ratio of apoB72 or apoB94 to B48-like protein was increased in the intact microsomes by 3- (Fig. 8B, left) and 6-fold (Fig. 8B, right) , respectively, by MTP expression. MTP expression also reduced the accessibility of the full-length apoBs to exogenous trypsin. In apoB72-transfected cells (Fig.  8C, left) , the trypsin-inaccessible portion of apoB72 in the microsomes was increased from 20% in cells transfected with apoB72 alone to 40% in cells cotransfected with MTP (compare apoB72 bands in lanes 1 and 2 of Fig. 8A) . Similarly, in apoB94-transfected cells (Fig. 8C, right) , the trypsin-inaccessible portion of apoB94 was increased from 4 to 45% by MTP expression. These results suggest that more full-length apoB proteins were protected from tryptic digestion by MTP expression, either S-labeled apoB94 (q) and B48-like (f) proteins were immunoprecipitated from cells at indicated times, resolved by SDS-PAGE, and subjected to fluorography (top). Radioactivity associated with apoB94 and B48-like proteins (both bands of the doublet) was quantified by scanning densitometry (bottom). B, the ratio of radiolabeled apoB94 and B48-like protein at each time point with (filled bars) or without (open bars) MTP expression. C, effect of coexpression of apoB15 or apoA-I on the formation of B48-like proteins in apoB94-transfected cells. COS-7 cells were either transfected with apoB94 alone, or cotransfected with the apoB94 plus apoB15 (B94ϩB15) or apoA-I (B94ϩA-I) cDNA. One day after transfection, cells were cultured in lipid feeding medium for 20 h. ApoB94 and B48-like proteins were detected from cell lysate by immunoblotting as described in Fig. 2 . D, effect of coexpression of apoB15 or apoA-I on the formation of B48-like proteins in apoB72-transfected cells. The experiments were performed essentially the same as C, except that apoB72 was used for transfection. Expression of the recombinant apoA-I and apoB15 in the transfected cells was verified by immunoblotting using monoclonal antibodies 5F6 (40) and 1D1 (32), respectively (data not shown). Experiments with apoB and MTP cotransfected cells are presented at the left for comparison. because the protein was translocated into the ER lumen or because the protein assumed a trypsin-resistant conformation through MTP-mediated lipidation. The integrity of the microsome preparations was confirmed by the nearly complete protection of the protein disulfide isomerase, an ER resident protein, from exogenous trypsin digestion (Fig. 8A, bottom) . Notably, the B48-like proteins in apoB94 or apoB72 producing cells were also sensitive to exogenous trypsin, suggesting that a portion of these proteins might also exist as transmembrane intermediates.
Effect of ALLN on the Production of ApoB48-like
ProteinsFinally, we examined whether or not the formation of B48-like proteins that was observed in apoB72-or apoB94-transfected cells was sensitive to ALLN, a cysteine protease inhibitor. Data summarized in Fig. 9 show that in the presence of ALLN, incorporation of [ 35 S]methionine into apoB94 and apoB72 was increased by 31 and 15%, respectively at the end of 2-h labeling. However, ALLN did not preclude the formation of B48-like proteins; their synthesis was also increased by 27 and 7%, respectively, in apoB94-and apoB72-transfected cells. The lack of an effect of ALLN on B48-like protein formation was readily apparent when the data were expressed as a ratio of apoB72/ B48-like or apoB94/B48-like proteins (Fig. 9C) .
DISCUSSION
The Ability of ApoB to Recruit Lipid and the Requirement for MTP Are Functions of ApoB Length-Heterologous cell systems (i.e., nonhepatic and nonintestinal cell lines) have recently been used to investigate the interplay among cellular lipogenesis, MTP, and specific apoB protein sequences during LpB assembly and secretion (4, 5) . The work to date has only examined secretion of a rather small N-terminal portion of apoB (i.e. ՅapoB53), which is not sufficient to assemble large lipoprotein particles. In the current study, we tested the roles of MTP and lipid biosynthesis in lipoprotein production using four larger truncated apoB forms, namely apoB60, apoB72, apoB75, and apoB94, in addition to seven small species ranging from apoB15 to apoB53. The present data not only confirm that MTP indeed facilitates LpB assembly and secretion but also indicate that the stimulatory effect of MTP on lipoprotein secretion increases as the apoB length increases. Although the short apoB forms, such as apoB15, apoB18, apoB23, and apoB29, could be secreted by COS cells without MTP expression (Fig. 1) , only trace amounts of apoB42 (not shown) and B48-like protein (Fig. 2B) were secreted in the absence of MTP, and secretion of apoB42 was enhanced 14-fold by MTP expression. In contrast, 3) were subjected to Northern blot analysis using a human apoB probe (cDNA nucleotides 3194 -3835). The human apoB48 mRNA from transfected COS-7 cells (lane 3) and the full-length human apoB100 RNA from HepG2 cells (lane 5) were used as size makers (14 and 7 kb, respectively). The identity of the band that migrated more slowly than B72 mRNA in pB48- 35 S]methionine/cysteine for 1 h and then incubated in chase medium for up to 2 h. The radiolabeled apoB proteins were recovered from the cell lysates and chase medium by immunoprecipitation, resolved by SDS-PAGE, and subjected to fluorography. Representative fluorograms are shown on the top eight panels. In A, the x-ray film was exposed for 20 h for cell samples and 24 (top right) or 50 h (bottom right) for medium samples. In B, the x-ray film was exposed for 16 h for cell samples and 24 h for medium samples. No bands were detected in B94-MTP or B72-MTP medium samples when exposure time was increased to 50 h. Radioactivity associated with apoB94 (indicated by downward pointing arrows) and B48-like protein (indicated by arrows on the right) in A was quantified by scanning densitometry, and that associated with apoB72 and B48-like protein in B was quantified by scintillation counting (bottom eight panels). Repetition of the experiments gave essentially identical results.
secretion of the large apoB species (i.e. from apoB53 to apoB94) depends entirely upon MTP expression. Furthermore, whereas MTP-stimulated secretion of apoB53 and apoB72 was observed when cells were cultured in serum-free medium, supplementation with serum and oleate is absolutely required for the secretion of apoB94 ( Fig. 2A) . It has been shown that the assembly of apoB nascent polypeptides with lipids occurs concurrently during apoB translation or translocation (6) . The present data indicate that secretion of the N-terminal portion of apoB, such as apoB15 and apoB18 that contain mainly the amphipathic ␣1 domain (33), does not require MTP activity (Fig. 1A) , probably because this portion of the apoB protein represents a folded ␣-helical globular domain and is not engaged in lipid assembly (8) . The stimulatory effect of MTP on apoB secretion is manifest when the apoB forms are equal to or longer than apoB23, (Fig. 1A) , which is the minimum length of apoB required to assemble lipoproteins with a nonpolar lipid core (8) . Thus, assembly of a neutral lipid core is most likely initiated by translocation of the lipid binding sequences downstream of the C terminus of apoB23. Notably, secretion of short apoB truncation variants as lipoproteins (e.g. apoB41) by cells that do not express MTP has been reported (34) . In the present studies we have also observed secretion of apoB23, apoB29, apoB42, and B48-like protein as HDL particles from COS cells in the absence of MTP (data not shown) suggesting that the N-terminal apoB sequences could indeed mediate lipid recruitment autonomously during lipoprotein assembly. Apparently, the autonomous assembly process mediated by apoB sequences occurs inefficiently and assembly becomes more dependent upon MTP activity as the apoB peptide length increases. Thus, the extent of the involvement of MTP in LpB assembly is directly related to the ability of apoB to recruit neutral lipids. Secretion of apoB94 and apoB72 as HDL by the transfected COS cells (Fig.  4) was somewhat unexpected. In transfected hepatic cells, secretion of large truncated apoB (i.e. ՆapoB72) associated with HDL was rarely observed (8) . The HDL-like apoB100-containing particles have been observed within subcellular fractions of HepG2 cells, but none of these particles were secreted, and apparently they were degraded (6) . The ability of COS-7 cells to secrete apoB94 and apoB72 as HDL rather than entirely degrade them may reflect differences in the post-translational degradation mechanisms between hepatic and COS-7 cells (see below).
Cotranslational Production of ApoB48-like Protein Is Attenuated by MTP Expression-In addition to facilitating assembly and secretion of LpB, MTP expression also decreases the proteolysis of large apoB polypeptides (ϾapoB53), inhibiting formation of B48-like proteins. Several mechanisms have been evaluated and eliminated as causes of the marked decrease in intracellular steady state levels of B48-like protein in the presence of MTP ( Figs. 2A and 5) . First, because only a small proportion of the newly synthesized B48-like proteins are secreted, the marked decrease in the intracellular steady state levels of B48-like protein cannot be entirely accounted for by increased secretion of the protein in the presence of MTP. Second, the decreased B48-like protein levels observed in the cells cannot be explained by increased post-translational degradation, because pulse-chase analysis has revealed that MTP expression has little effect on the stability of all the apoB proteins (Fig. 6) . Thus, the decreased levels of B48-like proteins in the MTP-expressing cells are the result of decreased production. Because Northern blot analysis has eliminated the involvement of the 7-kb apoB RNA species (Fig. 7) in the reduction of B48-like protein production and pulse-chase studies have excluded the possibility of B48-like proteins being products of post-translational degradation of precursor proteins (Figs. 5A and 6 ), we conclude that the formation of B48-like proteins is cotranslational, most likely by cleavage of apoB during protein translation. Exposure of proteolytically sensitive sites of apoB may result from a prolonged arrest in translocation before the entire apoB polypeptide has been synthesized. This cotranslational degradation of apoB cannot be precluded solely by supplementation with oleate and serum (Fig. 2) . Rather, production of B48-like proteins decreases markedly when MTP, a protein normally present in the ER of lipoprotein producing cells, is coexpressed. Formation of B48-like proteins with discrete sizes may suggest the existence of a degradation "hot spot" near the C terminus of apoB48. Unlike post-translational degradation of apoB where the full-length apoB precursor could be detected, the cotranslational cleavage occurs prior to or soon after completion of the entire protein and precludes the detection of C-terminal sequences downstream of the B48-like protein.
Translocation Arrest of ApoB-Translocation of apoB across the ER membrane is a complex process and is perhaps the rate-limiting step in LpB synthesis. One issue that remains controversial is whether translocation of apoB is a cotranslational or a post-translational event. Chuck et al. (9) have observed that translocation of apoB15 proceeds post-translationally through discrete stop-and-restart stages mediated by pause transfer sequences. However, such post-translational pausing of apoB was not observed by other investigators (35) . Another issue upon which researchers are in sharp disagreement is how and where the pause transfer occurs. Some investigators (10, 11) suggested that the pauses were caused by interaction between the pause transfer sequences and the ER membrane, while others (36) suggested that the pauses were mediated by the interaction between apoB sequences and ribosome. The importance of the membrane phospholipid composition in apoB translocation has been demonstrated using rat hepatocytes abnormally enriched in phosphatidylmonomethylethanolamine, in which translocation of apoB across the ER membrane was impaired (25) . Thus, uninterrupted translocation of apoB and LpB assembly may be achieved through an interplay of multiple factors including specific amino acids of apoB, specific phospholipids of the ER membrane, and MTP, in addition to active lipogenesis in the ER. Impairment of any one of the factors may result in prolonged or delayed apoB translocation and aborted LpB assembly. Based on our current results, we would propose a further refinement of the model (37) for the assembly of LpB and for the formation of degradation products of translocation arrested apoB intermediates. In this model, translocation of the N-terminal portion (a folded ␣-helical globular domain (33)) of apoB does not require MTP activity (Fig. 10A) . Assembly of neutral lipid is initiated by subsequent translocation of the downstream amphipathic sequences, and this process is facilitated by MTP as the length of apoB increases (Fig. 10, B and C) . This cotranslational and cotranslocational assembly of LpB may be interrupted by insufficient lipid transfer owing to the lack of lipid availability or MTP activity. When this occurs, the rate of apoB translocation will lag behind its translation. The untranslocated apoB sequences, especially the ␤ strands that avidly bind to lipids, may associate with the ER membrane and prevent continued apoB translocation (Fig. 10, A* and B*) . The ␤ strands are clustered in two regions of apoB (Fig. 10, bottom) : one between the N-terminal 18 -43% of apoB (␤1 domain), and the other between 58 and 85% (␤2 domain) (33) . Delayed translocation of sequences between the C termini of apoB53 and apoB60 that contain the ␤2 domain sequences may render apoB susceptible to degradation during chain elongation (i.e. cotranslational). Indeed, B48-like proteins are produced only by cells transfected with apoB species equal to or longer than apoB60, and there is virtually no B48-like proteins produced by cells expressing apoB53 (Fig. 10,  inset) . We propose that MTP-assisted lipid transfer may accelerate translocation of the amphipathic ␤ strands into the lumen, preventing their association with the ER membrane, thereby attenuating the cotranslational degradation of apoB on the ER membrane.
The concept and evidence for degradation of translocation arrested apoB was first presented by Davis and co-workers (12) using Chinese hamster ovary cells in which proteins the size of ϳ70 -85 kDa derived from the N terminus of apoB100 were observed. Because the 85-kDa protein and 220-kDa proteins are terminated at discrete sites preceding the N terminus of the amphipathic ␤1 and ␤2 domains (Fig. 10 , A* and B*, respectively), it is tempting to postulate that both proteins could be the result of proteolytic cleavage of translocation arrested nascent apoB polypeptides caused by prolonged association of the ␤ strands with the ER membrane. The difference between formation of the 85-kDa protein and that of the 220-kDa protein is that the former could be inhibited by ALLN (12, 38) , whereas the latter is insensitive to ALLN treatment. Recently, Ginsberg et al. (39) have presented evidence suggesting the existence of an ALLN-resistant but dithiothreitol-sensitive protease in HepG2 cells. Further experiments are required to define mechanisms responsible for the formation of the 220-kDa proteolytic cleavage product. It was noted that both apoB94 (Fig. 6A) and apoB72 (Fig. 6B ) expressed in the trans- that have yet to be defined biochemically. Translocation arrest of nascent apoB chains is proposed to be mediated by amphipathic ␤ strands associated with the ER membranes (see text for details). Inset, immunoblots of transiently expressed apoB48, apoB53, and apoB60 in COS-7 cells. Bottom, location of amphipathic ␣ helices (␣1, ␣2, and ␣3) and ␤ strands (␤1 and ␤2) within human apoB100 (according to Segrest et al. (33) ).
fected cells exhibited an extended intracellular retention time (t1 ⁄2 Ͼ 2 h). The prolonged retention of human apoB was also noted in stably transfected HeLa cells 3 but not in transfected hepatic cells (15, 16) in which the newly synthesized apoB proteins were rapidly degraded post-translationally. The difference in post-translational apoB degradation between COS and hepatic cells may reflect the absence of a hepatic-specific apoB degradation mechanism in the nonhepatic cells.
In conclusion, our data indicate that MTP facilitates the secretion of apoB proteins longer than apoB18 from nonhepatic COS cells and reduces the formation of a 220-kDa proteolytic cleavage product from apoB forms equal to or longer than apoB60. We hypothesize that the 220-kDa protein may result from cotranslational proteolysis of a translocation-arrested apoB polypeptide and that the attenuated production of the 220-kDa proteins may be attributable to the MTP-assisted apoB translocation and LpB assembly.
